CIK 0001339005 · <br>Emerging growth company
FEMASYS INC
Sign in to watch- Ticker
- FEMY
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113713499
- Phone
- 770-500-3910
- Business address
- 3950 JOHNS CREEK COURT, SUITE 100, SUWANEE, GA, 30024
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-07 | Elefant Dov Chief Financial Officer | Other acquisition · Senior Secured Convertible Notes | +0 | |||
| 2025-11-07 | Elefant Dov Chief Financial Officer | Other acquisition · Series A-1 Warrants | +34,122 | 34,122 | ||
| 2025-11-07 | Elefant Dov Chief Financial Officer | Other acquisition · Series B-1 Warrants | +34,122 | 34,122 | ||
| 2025-11-07 | Elefant Dov Chief Financial Officer | Other acquisition · Series C-1 Warrants | +34,122 | 34,122 | ||
| 2025-08-27 | Elefant Dov Chief Financial Officer | Other acquisition | +38,828 | 58,436 | ||
| 2025-08-27 | Elefant Dov Chief Financial Officer | Other acquisition · Common Warrants (right to buy) | +38,828 | 38,828 | ||
| 2025-08-27 | Lee-Sepsick Kathy Chief Executive Officer | Other acquisition | +48,535 | 360,627 | ||
| 2025-08-27 | Lee-Sepsick Kathy Chief Executive Officer | Other acquisition · Common Warrants (right to buy) | +48,535 | 48,535 | ||
| 2025-06-25 | Uzialko Edward R Director | Grant or award · Stock Option (Right to Buy) | +17,600 | 17,600 | ||
| 2025-06-25 | Milnes Alistair Director | Grant or award · Stock Option (Right to Buy) | +17,600 | 17,600 | ||
| 2025-06-25 | Larsen Charles Director | Grant or award · Stock Option (Right to Buy) | +17,600 | 17,600 | ||
| 2025-06-25 | Silverman Joshua Director | Grant or award · Stock Option (Right to Buy) | +17,600 | 17,600 | ||
| 2025-06-23 | Nicholas Kelley Stinson Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-06-02 | Larsen Charles Director | Other acquisition | +24,510 | $1.02 | $25K | 55.99 |
| 2025-06-02 | Currie Daniel Scott Chief Operating Officer | Other acquisition | +19,608 | $1.02 | $20K | 86,275 |
| 2025-06-02 | Elefant Dov Chief Financial Officer | Other acquisition | +19,608 | $1.02 | $20K | 19,608 |
| 2025-06-02 | Lee-Sepsick Kathy Chief Executive Officer | Other acquisition | +34,314 | $1.02 | $35K | 312,092 |
| 2025-01-29 | Lee-Sepsick Kathy Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +59,849 | 59,849 | ||
| 2025-01-29 | Lee-Sepsick Kathy Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +120,353 | 120,353 | ||
| 2025-01-29 | Lee-Sepsick Kathy Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +262,700 | 262,700 |
Page 3 of 7 · 127 trades